Publications

All the publications

• Research Publications
• Whitepapers
• Conference Presentations (ISPOR)
• Conference Presentations (Other)

Research Publications

• Furber, A., Martin, A., Bertuzzi, A. et al. (2025) Burden of illness in tuberous sclerosis complex-associated epilepsy: a systematic literature review of epidemiology, health-related quality of life, costs and resource use. Orphanet J Rare Dis 20, 609 . doi: 10.1186/s13023-025-03975-y
• Chaumont A, Martin A, Flamaing J, Wiseman DJ, Vandermeulen C, Jongert E, Doherty TM, Buchy P, Varga SM, Warter L. (2025) Host immune response to respiratory syncytial virus infection and its contribution to protection and susceptibility in adults: a systematic literature review. Expert Rev Clin Immunol. 21(6):745-760. doi: 10.1080/1744666X.2025.2494658. PMID: 40278893.
• Martin A, La Rosa GRM, Rice H, Bertuzzi A, Witkowski M, Anastasi E, Geraci G, Polosa R; DiaSmokeFree Working Group. Pharmacological interventions for smoking cessation in Type 2 diabetes: A systematic review with meta-analysis and GRADE evaluation. Diabetes Res Clin Pract. 2025 Jun;224:112202. doi: 10.1016/j.diabres.2025.112202. PMID: 40294654.
• Angus J., Connolly S., Letton W., Martin C., Martin A. (2023) A systematic literature review of the clinical signs and symptoms of veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation in adults and children. eJHaem 4(1):199-206. doi: 10.1002/jha2.612
• Bertuzzi A., Martin A., Clarke N., Springate C., Ashton R., Smith W., Orlowski A., McPherson D. (2023) Clinical, humanistic and economic outcomes, including experiencing of patient safety events, associated with admitting patients to single rooms compared with shared accommodation for acute hospital admissions: A systematic review and narrative synthesis. BMJ Open 13(5):e068932. doi: 10.1136/bmjopen-2022-068932
• Cornu J.-N., Zantek P., Burtt G., Martin C., Martin A., Springate C., Chughtai B. (2023) Minimally Invasive Treatments for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis. European Urology 83(6):534-547. doi: 10.1016/j.eururo.2023.02.028
• Burtt G., Springate C., Martin A., Woodward E., Zantek P., Al Jaafari F., Muir G., Misrai V. (2022) The Efficacy and Safety of Laser and Electrosurgical Transurethral Procedures for the Treatment of BPO in High-Risk Patients: A Systematic Review. Research and Reports in Urology 14():247-257. doi: 10.2147/RRU.S361956
• Martin C., Luteijn M., Letton W., Robertson J., McDonald S. (2021) A model framework for projecting the prevalence and impact of Long-COVID in the UK. PLoS ONE 16(12):e0260843. doi: 10.1371/journal.pone.0260843
• Martin C., McDonald S., Bale S., Luteijn M., Sarkar R. (2021) Construction of a demand and capacity model for intensive care and hospital ward beds, and mortality from COVID-19. BMC medical informatics and decision making 21(1):138. doi: 10.1186/s12911-021-01504-y
• Buck J., Fromings Hill J., Martin A., Springate C., Ghosh B., Ashton R., Lee G., Orlowski A. (2021) Reasons for discontinuing oral anticoagulation therapy for atrial fibrillation: A systematic review. Age and Ageing 50(4):1108-1117. doi: 10.1093/ageing/afab024
• Kam J.,  Tejiozem A., Martin A., Turner A. (2023) Emergency department acuity measurement and process: quick scoping review. NHS Midlands and Lancashire. (Review: NHS Midlands and Lancashire)

Whitepapers

• Letton W. and King E. (2023) Assessing the accuracy of AI indexing of abstracts in a literature review.
• Longevity Science Panel. (2021) The COVID-19 Pandemic.
• Longevity Science Panel. (2018) Life expectancy: Is the socio-economic gap narrowing?
• Longevity Science Panel. (2015) Public data for the private sector.
• Longevity Science Panel. (2014) What is ageing? Can we delay it?
• Crystallise (2024) Geroscience Focus Bulletin.

Conference Presentations (ISPOR)

• Bilimoria, J., Roussi K., Martin A, Edema C. HTA  league of nations – which bodies were most likely to approve submissions and for what disease area? Presented at ISPOR Europe 2025, Glasgow, UK, 10-12 November 2025
• Bilimoria J., Roussi K., Martin A., Edema C. HTA conflicts in Europe – agreeing to disagree? Presented at ISPOR Europe 2025, Glasgow, UK, 10-12 November 2025
• Roussi K., Rice H., Bertuzzi A., Martin A. Evaluation of the use of ChatGPT in data extraction for systematic literature reviews: friend, foe or fiction? Presented at ISPOR Europe 2025, Glasgow, UK, 10-12 November 2025 
• Edema C., Martin A., Martin C., King E., Wesson F., Bertuzzi A., Witkowski M. (2024) Cost-Effectiveness of a Large Language Model for Indexing Biomedical Abstracts. Presented at ISPOR Europe 2024, Barcelona, Spain, 17th-20th November 2024
• Patel T., Martin A., Gould H., King E., Roussi K. (2024) What Interventions Have Been Shown to Improve the Quality of Life in People Who Are Homeless or Have Insecure Housing? Presented at ISPOR Europe 2024, Barcelona, Spain, 17th-20th November 2024
• Rice H., Roussi K., King E., Martin A. (2024) Frequency and Type of Errors in Data Extraction Within Systematic Literature Reviews. Presented at ISPOR Europe 2024, Barcelona, Spain, 17th-20th November 2024
• Roussi K., Rice H., King E., Martin A. (2024) Opportunities and Limitations in the Use of AI to Assist With Data Extraction in Systematic Literature Reviews. Presented at ISPOR Europe 2024, Barcelona, Spain, 17th-20th November 2024
• Edema C., Martin A., Martin C., Bertuzzi A., King E., Wesson F., Witkowski M. (2024) Evaluating the Performance of a Large Language Model (LLM) Compared to Humans in a Complex Categorization Task. Presented at ISPOR Europe 2024, Barcelona, Spain, 17th-20th November 2024
• Edema C., Rutherford L., Martin A., Martin C., Bertuzzi A., King E., Letton W. (2024) Is a Large Language Model (LLM) More Accurate Than Human Researchers in Correctly Identifying Diseases in Biomedical Abstracts? A Pilot Study. Value in Health 27(6):S351. Presented at ISPOR 2024, Atlanta (GA), United States, 5th-8th May 2024 doi: 10.1016/j.jval.2024.03.2437
• Clarke N., Martin A., Witkowski M., Roussi K., King E., Patel T., Bilimoria J., Kam J., Gould H., Rice H. (2024) MSR13 What Most Concerns Patients about the Impact of Diabetes and Its Treatment on Their Ability to Drive? Value in Health 27(6):S261-S262. Presented at ISPOR 2024, Atlanta (GA), United States, 5th-8th May 2024 doi: 10.1016/j.jval.2024.03.1446
• Rutherford L., Ahdesmaki O., Clarke N., Martin A., Witkowski M. (2023) The Accuracy of Network Meta-Analysis Feasibility Predictions Based on Data Included Only in the Abstracts of Trial Publications. Value in Health 26(12):S551. Presented at ISPOR Europe 2023, Copenhagen, Denmark, 11th-15th November 2023 doi: 10.1016/j.jval.2023.09.2962
• Rutherford L., Ahdesmaki O., Clarke N., Martin A., Witkowski M. (2023) Planning Phase 3 Clinical Trials More Efficiently Using an Evidence-Mapping Approach Value in Health 26(12):S553. Presented at ISPOR Europe 2023, Copenhagen, Denmark, 11th-15th November 2023 doi: 10.1016/j.jval.2023.09.2972
• Ahdesmaki O., Springate C., Martin A. (2022) EE261 Cost and Resource Studies in Endometriosis: An Evidence Map. Value in Health 25(12):S104-S105. Presented at ISPOR Europe 2022, Vienna, Austria, 6th-9th November 2022 doi: 10.1016/j.jval.2022.09.509
• Springate C., Martin A., Ghosh B., Gould H., Rice H., Rutherford L., Furber A. (2020) PRS52 RAPID Review of ACUTE Respiratory Distress Syndrome in Adults. Value in Health 23(Supplement 2):S726. Presented at ISPOR Europe 2020, Virtual, Online, 16th-19th November 2020 doi: 10.1016/j.jval.2020.08.1932
• Furber A., Springate C., Martin A., Ghosh B., Gould H., Rice H., Rutherford L. (2020) PNS194 Within-Person Comparison Diagnostic Studies: A Systematic Review of Quality Assessment Tools. Value in Health 23(Supplement 2):S673. Presented at ISPOR Europe 2020, Virtual, Online, 16th-19th November 2020 doi: 10.1016/j.jval.2020.08.1638
• Molnar D., D’Souza V., Martin A. (2020) PRS67 How the Disease Progression Is Captured in COPD Models? A Systematic Literature Review of Disease and Economic Models. Value in Health 23(Supplement 2):S729-S730. Presented at ISPOR Europe 2020, Virtual, Online, 16th-19th November 2020 doi: 10.1016/j.jval.2020.08.1947
• Martin C., Hines J.E., Pichardo C. (2019) PCN450 FITTING A MIXTURE MODEL OF CANCER EXCESS MORTALITY RATES WITH A TRANSFORMATION STEP, TO CANCER RELATIVE SURVIVAL DATA. Value in Health 22(Supplement 3):S523. Presented at ISPOR Europe 2019, Copenhagen, Denmark, 2nd-6th November 2019 doi: 10.1016/j.jval.2019.09.642
• Martin A., Furber A.M. (2019) PMS35 EVIDENCE MAP OF ECONOMIC EVALUATIONS IN RHEUMATOID ARTHRITIS. Value in Health 22(Supplement 3):S700. Presented at ISPOR Europe 2019, Copenhagen, Denmark, 2nd-6th November 2019 doi: 10.1016/j.jval.2019.09.1579
• Furber A.M., Martin A. (2018) EVIDENCE MAP OF PATIENT REPORTED OUTCOME STUDIES IN NON-HODGKIN LYMPHOMA SINCE 1960. Value in Health 21(Supplement 3):S77. Presented at ISPOR Europe 2018, Barcelona, Spain, 10th-14th November 2018 doi: 10.1016/j.jval.2018.09.454
• Hines J.E., Springate C.E., Martin C. (2018) MODELLING LIKELY CARDIOVASCULAR DISEASE MORTALITY WITH PCSK9 INHIBITORS USING A SYNTHETIC POPULATION. Value in Health 21(Supplement 3):S377. Presented at ISPOR Europe 2018, Barcelona, Spain, 10th-14th November 2018 doi: 10.1016/j.jval.2018.09.2244
• Hines J.E., Martin A. (2018) EVIDENCE MAP OF ECONOMIC EVALUATIONS OF EXERCISE THERAPY PUBLISHED SINCE 2015. Value in Health 21(Supplement 3):S320. Presented at ISPOR Europe 2018, Barcelona, Spain, 10th-14th November 2018 doi: 10.1016/j.jval.2018.09.1909
• Martin C., Springate C.E. (2018) SYNTHETIC SAMPLE GENERATION OF THE 4S STUDY PLACEBO POPULATION USING A STOCHASTIC RESAMPLING TECHNIQUE. Value in Health 21(Supplement 3):S375. Presented at ISPOR Europe 2018, Barcelona, Spain, 10th-14th November 2018 doi: 10.1016/j.jval.2018.09.2234
• Martin C., Springate C.E. (2018) Synthetic sample generation representing the english population using spearman rank correlation and chomsky decomposition. Value in Health 21():S221. Presented at ISPOR 2018, Baltimore (MD), United States, 19th-23th May 2018 doi: 10.1016/j.jval.2018.04.1497
• Martin A. (2017) Evidence map of costs studies in cystic fibrosis since 2000. Value in Health 20(9):A643. Presented at ISPOR Europe 2017, Glasgow, United Kingdom, 4th-8th Novemer 2017 doi: 10.1016/j.jval.2017.08.1481
• Martin A. (2017) Evidence map of cost-utility models in multiple sclerosis published since 1960. Value in Health 20(5):A194. Presented at ISPOR 2017, Boston (MA), United States, 20th-24th May 2020 doi: 10.1016/j.jval.2017.05.005
• Martin A. (2017) Pro instruments used in studies of bipolar disorder since 1960. Value in Health 20(5):A299. Presented at ISPOR 2017, Boston (MA), United States, 20th-24th May 2020 doi: 10.1016/j.jval.2017.05.005
• Martin A. (2017) Pro instruments used in studies of ankylosing spondylitis since 1960. Value in Health 20(5):A150. Presented at ISPOR 2017, Boston (MA), United States, 20th-24th May 2020 doi: 10.1016/j.jval.2017.05.005
• Martin A. (2017) Evidence map of indirect costs in psoriasis and psoriatic arthritis since 1960. Value in Health 20(9):A804. Presented at ISPOR Europe 2017, Glasgow, United Kingdom, 4th-8th Novemer 2017 doi: 10.1016/j.jval.2017.08.3070
• Martin A. (2017) Evidence map of economic burden studies in pancreatitis since 1960. Value in Health 20(5):A184. Presented at ISPOR 2017, Boston (MA), United States, 20th-24th May 2020 doi: 10.1016/j.jval.2017.05.005
• Martin A. (2017) Pro instruments used in studies of hepatitis C since 1960. Value in Health 20(5):A185. Presented at ISPOR 2017, Boston (MA), United States, 20th-24th May 2020 doi: 10.1016/j.jval.2017.05.005
• Martin A. (2017) Pro instruments used in studies of pulmonary hypertension since 1960. Value in Health 20(9):A622. Presented at ISPOR Europe 2017, Glasgow, United Kingdom, 4th-8th Novemer 2017 doi: 10.1016/j.jval.2017.08.1360
• Martin A. (2017) Pro instruments used in studies of skin cancer since 1960. Value in Health 20(9):A452-A453. Presented at ISPOR Europe 2017, Glasgow, United Kingdom, 4th-8th Novemer 2017 doi: 10.1016/j.jval.2017.08.307
• Martin A. (2017) Evidence map of cost-benefit, cost-effectiveness and cost-utility models in dementia published since 1960. Value in Health 20(9):A724-A725. Presented at ISPOR Europe 2017, Glasgow, United Kingdom, 4th-8th Novemer 2017 doi: 10.1016/j.jval.2017.08.1955
• Martin A. (2017) Evidence ma p of indirect costs in psoriasis and psoriatic arthritis since 1960. Value in Health 20(9):A804. Presented at ISPOR Europe 2017, Glasgow, United Kingdom, 4th-8th Novemer 2017 doi: 10.1016/j.jval.2017.08.3070
• Martin A. (2016) Pro instruments for musculoskeletal disorders used in studies published since 2005: Which diseases have had the most tools developed? Value in Health 19(7):A543. Presented at ISPOR Europe 2016, Vienna, Austria, 29th October-2nd November 2016 doi: 10.1016/j.jval.2016.09.1137
• Martin A. (2016) Pro instruments for mental disorders used in studies published since 2005: Which diseases have had the most tools developed? Value in Health 19(7):A527. Presented at ISPOR Europe 2016, Vienna, Austria, 29th October-2nd November 2016 doi: 10.1016/j.jval.2016.09.1049
• Krohn J., Martin A., Martin C. (2016) Accuracy of natural language processing-based classifiers for automated identification of abstracts of studies on humanistic and economic burden of disease. Value in Health 19(7):A355. Presented at ISPOR Europe 2016, Vienna, Austria, 29th October-2nd November 2016 doi: 10.1016/j.jval.2016.09.051
• Challen R., Martin A., Martin C. (2016) Accuracy of text processing tokenisers for automated identificat ion of diseases and interventions in abstracts of studies on humanistic and economic burden of disease. Value in Health 19(7):A367. Presented at ISPOR Europe 2016, Vienna, Austria, 29th October-2nd November 2016 doi: 10.1016/j.jval.2016.09.123
• Martin A. (2016) Pro instruments used in studies published since 2005: Which populations and diseases have had the most tools developed? Value in Health 19(7):A486. Presented at ISPOR Europe 2016, Vienna, Austria, 29th October-2nd November 2016 doi: 10.1016/j.jval.2016.09.807
• Martin A. (2015) Economic burden in studies published in 2014: What type of gastrointestinal disorders, interventions and outcomes have been most commonly assessed? Value in Health 18(7):A624-A625. Presented at ISPOR Europe 2015, Milan, Italy, 7th-11th November 2015 doi: 10.1016/j.jval.2015.09.2196
• Martin A. (2015) Economic evaluations in infectious disease: Which infections, what settings and what type of economic evaluations were reported in papers published in 2014? Value in Health 18(7):A589. Presented at ISPOR Europe 2015, Milan, Italy, 7th-11th November 2015 doi: 10.1016/j.jval.2015.09.1510
• Martin A. (2015) Patient-reported outcomes in studies published in 2014: Which tools have been most commonly used in studies of musculoskeletal disorders? Value in Health 18(7):A653. Presented at ISPOR Europe 2015, Milan, Italy, 7th-11th November 2015 doi: 10.1016/j.jval.2015.09.2352
• Martin A. (2015) Patient-reported outcomes in studies published in 2014: Which disease areas have been the main focus of clinical research? Value in Health 18(7):A742. Presented at ISPOR Europe 2015, Milan, Italy, 7th-11th November 2015 doi: 10.1016/j.jval.2015.09.2855
• Martin A. (2015) Humanistic burden in dementia: Which tools were most commonly used in studies published in PubMed in 2014? Value in Health 18(7):A412-A413. Presented at ISPOR Europe 2015, Milan, Italy, 7th-11th November 2015 doi: 10.1016/j.jval.2015.09.990
• Martin A. (2015) Economic modelling studies published in 2014: Which disease areas have been the main focus of clinical research? Value in Health 18(7):A530. Presented at ISPOR Europe 2015, Milan, Italy, 7th-11th November 2015 doi: 10.1016/j.jval.2015.09.1647
• Martin A. (2015) Patient-reported outcomes in studies published in 2014: Which tools have been most commonly used in studies of respiratory disorders? Value in Health 18(7):A504. Presented at ISPOR Europe 2015, Milan, Italy, 7th-11th November 2015 doi: 10.1016/j.jval.2015.09.1434
• Martin A. (2015) Economic burden in studies published in 2014: What type of mental health disorders and outcomes have been most commonly assessed? Value in Health 18(7):A411-A412. Presented at ISPOR Europe 2015, Milan, Italy, 7th-11th November 2015 doi: 10.1016/j.jval.2015.09.985
• Martin A. (2015) Economic burden outcomes in studies published in 2014: Which disease areas have been the main focus of clinical research? Value in Health 18(7):A532-A533. Presented at ISPOR Europe 2015, Milan, Italy, 7th-11th November 2015 doi: 10.1016/j.jval.2015.09.1661
• Martin A., Martin C. (2015) When “alive after 5 years” does not mean “cured”: International patterns in cancer 10-to 20-year relative survival rates. Value in Health 18(7):A440. Presented at ISPOR Europe 2015, Milan, Italy, 7th-11th November 2015 doi: 10.1016/j.jval.2015.09.1078
• Martin A., Martin C. (2015) Simpson’s paradox: Why smoking reduces the risk of dying of cardiovascular disease. Value in Health 18(7):A383. Presented at ISPOR Europe 2015, Milan, Italy, 7th-11th November 2015 doi: 10.1016/j.jval.2015.09.826
• Martin A., Martin C. (2015) Modelling the likely impact of the obesity epidemic on mortality and cause of death in older adults. Value in Health 18(7):A663. Presented at ISPOR Europe 2015, Milan, Italy, 7th-11th November 2015 doi: 10.1016/j.jval.2015.09.2409
• Martin C., Martin A. (2015) Mortality trends in cancers: A new model to visualise the contribution of specific diseases, cohorts and coding changes to overall mortality improvement. Value in Health 18(7):A441. Presented at ISPOR Europe 2015, Milan, Italy, 7th-11th November 2015 doi: 10.1016/j.jval.2015.09.1080
• Martin C., Martin A. (2015) Mortality trends in cardiovascular disease: A new model to visualise the contribution of specific diseases, cohort effects and coding changes to overall mortality improvement. Value in Health 18(7):A383. Presented at ISPOR Europe 2015, Milan, Italy, 7th-11th November 2015 doi: 10.1016/j.jval.2015.09.825
• Martin C., Pichardo-Almarza C. (2013) Using a cause-of-death-based mortality model to identify the individuals who would benefit most from primary prevention with statins. Value in Health 16(7):A517. Presented at ISPOR Europe 2013, Dublin, Ireland, 2nd-6th November 2013 doi: 10.1016/j.jval.2013.08.1232

Conference Presentations (Other)

• Su W., Stricherz M., Martin A., Belsey J., Kemadjou E., DeAngelo D.J. (2023) A Meta-Analysis Comparing the Relative Efficacy of Pediatric-Inspired Regimens Versus Hyper-CVAD for the Treatment of Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Adolescents, Young Adults, and Adults. Blood 142(Supplement 1):3779. Presented at the 65th ASH Annual Meeting 2023, San Diego (CA), United States, 9th-12th December 2023 doi: 10.1182/blood-2023-173750
• Angus J., Letton W., Connolly S., Bilimoria J., Martin C. (2022) A SYSTEMATIC LITERATURE REVIEW (SLR) OF THE MANIFESTATIONS OF VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) AFTER HEMATOPOIETIC CELL TRANSPLANTATION (HCT) IN ADULTS VERSUS CHILDREN. HemaSphere 6():2372-2373. Presented at the Congress of the European Hematology Association, EHA 2022, Virtual Meeting, 15th-17th June 2022 doi: 10.1097/01.HS9.0000852292.38263.b8
• Angus J., Rutherford L., Moubarak L., Roussi K., Martin A. (2022) A Real-world Evidence Systematic Literature Review of the Metrics Used to Detect Venoocclusive Disease/Sinusoidal Obstruction Syndrome after Haematopoietic Cell Transplantation. British Journal of Haematology 197(SUPPL 1):218-219. Presented at the 62nd Annual Scientific Meeting of the British Society for Haematology 2022, Virtual Meeting, 3rd-5th April 2022 doi: 10.1111/bjh.18135
• Angus J., Rutherford L., Moubarak L., Roussi K., Martin A. (2022) A real-world evidence systematic literature review (slr) of the metrics used to detect veno-occlusive disease/sinusoidal obstruction syndrome (vod/sos) after haematopoietic cell transplantation (hct). Bone Marrow Transplantation 57():352-353. Presented at the 48th Annual Meeting of the European Society for Blood and Marrow Transplantation, EBMT 2022, Virtual Meeting, 19th-23th March 2022 doi: 10.1038/s41409-022-01798-0
• Ngonga Kemadjou E., Johnston R., Martin A. (2020) Minimal residual disease and the prediction of survival outcomes in chronic lymphocytic leukaemia: A pooled analysis of observational and clinical trial data. British Journal of Haematology 189(SUPPL 1):108-109. Presented at the 60th Annual Scientific Meeting of the British Society for Haematology 2020, Birmingham, United Kingdom, 27th-29th April 2020 doi: 10.1111/bjh.16638
• Furber A., Springate C. (2018) PRO instruments used in studies of prostate cancer since 1960. Quality of Life Research 27:S124. Presented at the 25th Annual Conference of the International Society for Quality of Life Research, ISOQOL 2018, Dublin, Ireland, 24th-27th October 2018 doi: 10.1007/s11136-018-1946-9
• Springate C. (2018) An evidence map of instruments for caregiver reported outcomes. Quality of Life Research 27:S128. Presented at the 25th Annual Conference of the International Society for Quality of Life Research, ISOQOL 2018, Dublin, Ireland, 24th-27th October 2018 doi: 10.1007/s11136-018-1946-9
• Martin C., Taylor P. (2013) Risk equivalents in hyperlipidaemia. Atherosclerosis 231(2):e7-e8. Presented at the 27th Annual Conference of HEART UK 2013, Bristol, United Kingdom, 3rd-5th July 2013 doi: 10.1016/j.atherosclerosis.2013.07.010